Samuel C. Blackman, HEAD OF R&D at Day One Biopharmaceuticals, Inc. (DAWN), sold 40,000 shares at $16.01 ($640K) on 2024-07-16, disclosed to the SEC on 2024-07-17.
Scheduled sale ($640k) by HEAD OF R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.01 | 20,000 | $320K | 50.0% |
| 2 | $16.01 | 20,000 | $320K | 50.0% |
| Total | $16.01 avg | 40,000 | $640K | 100% |
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |